Biomed company Topspin Medical Inc. (TASE:TOPMD), traded in Tel Aviv, is acquiring the activity of medical device company Barnev. The deal is with Swiss investment fund Aeris, which controls Barnev. Aeris will invest $2 million in the merged company for a 10% stake. The price per share at which the investment will be made is NIS 0.02, similar to TopSpin's opening share price today.
In addition, TopSpin plans to file a prospectus for a public offering in the coming months. Aeris will make its investment only if the merged company raises $3 million by the end of May.
These moves require the approval of 50% of the company's shareholders, as TopSpin is registered in Delaware. Following the announcement, TopSpin's share price fell 5%, giving a market cap of NIS 65.23 million.
Barnev has developed a product for tracking critical processes during labor. In 2006, it sought to raise $5 million in an IPO at a valuation of NIS 90 million after the money, but failed to achieve the desired value. So far, some $20 million have been invested in the company by Aeris, the Innomed Fund of the Jerusalem Global Ventures group, and Ofer Brothers.
Barnev is a graduate of the Naiot incubator. Its product is an ultrasound-based device that performs computerized monitoring of the birth process, specifically dilation of the cervix, which is currently examined manually. According to the company, manual examination is uncomfortable, inaccurate, and can cause infection. "Globes" has learned that the company has not yet managed to make substantial sales and educate the market to give up manual examination. It seems that the product's price is also a factor.
Published by Globes [online], Israel business news - www.globes-online.com - on March 10, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010